Cancer Important Breakthrough in Cancer Treatment?

Medical discovery could save millions of lives
An international team of researchers has now made a major scientific breakthrough in the treatment of various cancers. The new discovery could have the potential to treat millions of people with cancer successfully in the future and save so many people's lives.

The scientists from the Australian Walter and Eliza Hall Institute found in an investigation that a newly discovered compound can effectively kill a protein that is responsible for the growth of cancer. The compound, designated S63845, is designed to target the MCL1 protein. The physicians published the results of their study in the journal "Nature".

Cancer is a serious disease, which often leads to the death of those affected. Physicians now made a major breakthrough in the treatment of various cancers. (Image: crevis / fotolia.com)

Targeted treatment can kill cancer cells
The protein MCL1 keeps the cancer cells alive and has already been detected in a variety of cancers, say the experts. The inhibition of the protein is effective in targeting several different cancers. Targeted treatment of MLC1 effectively kills the affected cancer cells, explains Professor Guillaume Lessen of the Walter and Eliza Hall Institute.

Treatment especially effective for different types of blood cancer
It has also been shown that this type of treatment is particularly effective in the fight against blood cancer. This type of cancer includes, for example, acute myeloid leukemia, lymphoma and multiple myeloma. All of these cancers are particularly sensitive to compound S63845, adds Professor Lessene. This finding is a major scientific breakthrough and it is now only a matter of time until the first clinical trials begin, the authors explain.

Clinical trials should be initiated quickly
MCL1 is one of the most important pillars of cancer survival. Now we have found a way to weaken these cancer cells, say the doctors. In the near future, clinical trials on this topic are essential. In the end, millions of cancer patients could benefit from this new drug. Wei.

S63845 is not just targeted for a specific type of cancer
MCL1 is widely used in a variety of cancers. That's why we literally have the opportunity to conduct clinical trials on a wide range of cancers, the scientists explain. The potential benefits of S63845 could help many cancer patients because, unlike some medicines, they are not focused on just one disease. (As)